{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:09:09Z","timestamp":1787501349068,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T00:00:00Z","timestamp":1652313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T00:00:00Z","timestamp":1652313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s10840-022-01209-w","type":"journal-article","created":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T17:23:03Z","timestamp":1652376183000},"page":"153-163","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Circ-TLR4 promotes cardiac hypertrophy through recruiting FUS to stabilize TLR4 mRNA"],"prefix":"10.1007","volume":"65","author":[{"given":"Chao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4339-1235","authenticated-orcid":false,"given":"Jun","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangrong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziping","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,12]]},"reference":[{"key":"1209_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","volume":"65","author":"N Frey","year":"2003","unstructured":"Frey N, Olson EN. Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol. 2003;65:45\u201379.","journal-title":"Annu Rev Physiol"},{"key":"1209_CR2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","volume":"97","author":"I Shimizu","year":"2016","unstructured":"Shimizu I, Minamino T. Physiological and pathological cardiac hypertrophy. J Mol Cell Cardiol. 2016;97:245\u201362.","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"1209_CR3","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1111\/jcmm.14129","volume":"23","author":"L Zhu","year":"2019","unstructured":"Zhu L, Li C, Liu Q, Xu W, Zhou X. Molecular biomarkers in cardiac hypertrophy. J Cell Mol Med. 2019;23(3):1671\u20137.","journal-title":"J Cell Mol Med"},{"issue":"12","key":"1209_CR4","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nrg3074","volume":"12","author":"M Esteller","year":"2011","unstructured":"Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12(12):861\u201374.","journal-title":"Nat Rev Genet"},{"issue":"17","key":"1209_CR5","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.7150\/thno.21299","volume":"7","author":"WW Du","year":"2017","unstructured":"Du WW, Zhang C, Yang W, Yong T, Awan FM, Yang BB. Identifying and characterizing circRNA-Protein interaction. Theranostics. 2017;7(17):4183\u201391.","journal-title":"Theranostics"},{"issue":"5","key":"1209_CR6","doi-asserted-by":"publisher","first-page":"5588","DOI":"10.1002\/jcp.27384","volume":"234","author":"MA Altesha","year":"2019","unstructured":"Altesha MA, Ni T, Khan A, Liu K, Zheng X. Circular RNA in cardiovascular disease. J Cell Physiol. 2019;234(5):5588\u2013600.","journal-title":"J Cell Physiol"},{"key":"1209_CR7","doi-asserted-by":"crossref","unstructured":"Prestes PR, Maier MC, Woods BA, Charchar FJ. A guide to the short, long and circular RNAs in hypertension and cardiovascular disease. Int J Mol Sci. 2020;21(10).","DOI":"10.3390\/ijms21103666"},{"key":"1209_CR8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/978-981-13-1426-1_13","volume":"1087","author":"Q Zhou","year":"2018","unstructured":"Zhou Q, Zhang Z, Bei Y, Li G, Wang T. Circular RNAs as novel biomarkers for cardiovascular diseases. Adv Exp Med Biol. 2018;1087:159\u201370.","journal-title":"Adv Exp Med Biol"},{"issue":"11","key":"1209_CR9","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.1021\/acs.molpharmaceut.8b00691","volume":"15","author":"MA Shetab Boushehri","year":"2018","unstructured":"Shetab Boushehri MA, Lamprecht A. TLR4-based immunotherapeutics in cancer: A review of the achievements and shortcomings. Mol Pharm. 2018;15(11):4777\u2013800.","journal-title":"Mol Pharm"},{"issue":"1","key":"1209_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.bbrc.2019.06.015","volume":"516","author":"X Chen","year":"2019","unstructured":"Chen X, Xu S, Zhao C, Liu B. Role of TLR4\/NADPH oxidase 4 pathway in promoting cell death through autophagy and ferroptosis during heart failure. Biochem Biophys Res Commun. 2019;516(1):37\u201343.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"1209_CR11","doi-asserted-by":"publisher","first-page":"H1027","DOI":"10.1152\/ajpheart.00697.2018","volume":"316","author":"MV Singh","year":"2019","unstructured":"Singh MV, Cicha MZ, Nunez S, Meyerholz DK, Chapleau MW, Abboud FM. Angiotensin II-induced hypertension and cardiac hypertrophy are differentially mediated by TLR3- and TLR4-dependent pathways. Am J Physiol Heart Circ Physiol. 2019;316(5):H1027\u201338.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"1209_CR12","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s12038-018-9816-8","volume":"43","author":"RB Teixeira","year":"2018","unstructured":"Teixeira RB, Barboza TE, DEA CC, Siqueira R, DEC AL, Bonetto JHP, et al. Decreased PGC1- \u03b1 levels and increased apoptotic protein signaling are associated with the maladaptive cardiac hypertrophy in hyperthyroidism. J Biosci. 2018;43(5):887\u201395.","journal-title":"J Biosci"},{"issue":"1","key":"1209_CR13","doi-asserted-by":"publisher","first-page":"19232","DOI":"10.1038\/s41598-020-75301-4","volume":"10","author":"PB Katare","year":"2020","unstructured":"Katare PB, Nizami HL, Paramesha B, Dinda AK, Banerjee SK. Activation of toll like receptor 4 (TLR4) promotes cardiomyocyte apoptosis through SIRT2 dependent p53 deacetylation. Sci Rep. 2020;10(1):19232.","journal-title":"Sci Rep"},{"key":"1209_CR14","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3389\/fimmu.2017.00719","volume":"8","author":"PB Katare","year":"2017","unstructured":"Katare PB, Bagul PK, Dinda AK, Banerjee SK. Toll-like receptor 4 inhibition improves oxidative stress and mitochondrial health in isoproterenol-induced cardiac hypertrophy in rats. Front Immunol. 2017;8:719.","journal-title":"Front Immunol"},{"issue":"4","key":"1209_CR15","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1161\/HYPERTENSIONAHA.119.13022","volume":"74","author":"MOR Mian","year":"2019","unstructured":"Mian MOR, He Y, Bertagnolli M, Mai-Vo TA, Fernandes RO, Boudreau F, et al. TLR (Toll-Like Receptor) 4 antagonism prevents left ventricular hypertrophy and dysfunction caused by neonatal hyperoxia exposure in rats. Hypertension (Dallas, Tex\u202f: 1979). 2019;74(4):843\u201353.","journal-title":"Hypertension (Dallas, Tex : 1979)."},{"issue":"12","key":"1209_CR16","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nrg3813","volume":"15","author":"S Gerstberger","year":"2014","unstructured":"Gerstberger S, Hafner M, Tuschl T. A census of human RNA-binding proteins. Nat Rev Genet. 2014;15(12):829\u201345.","journal-title":"Nat Rev Genet"},{"key":"1209_CR17","doi-asserted-by":"publisher","first-page":"7098","DOI":"10.1038\/ncomms8098","volume":"6","author":"T Udagawa","year":"2015","unstructured":"Udagawa T, Fujioka Y, Tanaka M, Honda D, Yokoi S, Riku Y, et al. FUS regulates AMPA receptor function and FTLD\/ALS-associated behaviour via GluA1 mRNA stabilization. Nat Commun. 2015;6:7098.","journal-title":"Nat Commun"},{"issue":"36","key":"1209_CR18","doi-asserted-by":"publisher","first-page":"22085","DOI":"10.1074\/jbc.M115.674945","volume":"290","author":"YS Markandeya","year":"2015","unstructured":"Markandeya YS, Phelan LJ, Woon MT, Keefe AM, Reynolds CR, August BK, et al. Caveolin-3 overexpression attenuates cardiac hypertrophy via inhibition of T-type Ca2+ current modulated by protein kinase C\u03b1 in cardiomyocytes. J Biol Chem. 2015;290(36):22085\u2013100.","journal-title":"J Biol Chem"},{"issue":"7","key":"1209_CR19","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1093\/cvr\/cvz215","volume":"116","author":"H Li","year":"2020","unstructured":"Li H, Xu JD, Fang XH, Zhu JN, Yang J, Pan R, et al. Circular RNA circRNA_000203 aggravates cardiac hypertrophy via suppressing miR-26b-5p and miR-140-3p binding to Gata4. Cardiovasc Res. 2020;116(7):1323\u201334.","journal-title":"Cardiovasc Res"},{"issue":"24","key":"1209_CR20","doi-asserted-by":"publisher","first-page":"7268","DOI":"10.7150\/thno.33006","volume":"9","author":"Y Sun","year":"2019","unstructured":"Sun Y, Chen C, Xue R, Wang Y, Dong B, Li J, et al. Maf1 ameliorates cardiac hypertrophy by inhibiting RNA polymerase III through ERK1\/2. Theranostics. 2019;9(24):7268\u201381.","journal-title":"Theranostics"},{"issue":"6","key":"1209_CR21","doi-asserted-by":"publisher","first-page":"3678","DOI":"10.1111\/jcmm.15067","volume":"24","author":"Q Fang","year":"2020","unstructured":"Fang Q, Liu T, Yu C, Yang X, Shao Y, Shi J, et al. LncRNA TUG1 alleviates cardiac hypertrophy by targeting miR-34a\/DKK1\/Wnt-\u03b2-catenin signalling. J Cell Mol Med. 2020;24(6):3678\u201391.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"1209_CR22","doi-asserted-by":"publisher","first-page":"e006525","DOI":"10.1161\/CIRCHEARTFAILURE.119.006525","volume":"13","author":"J Yu","year":"2020","unstructured":"Yu J, Yang Y, Xu Z, Lan C, Chen C, Li C, et al. Long noncoding RNA Ahit protects against cardiac hypertrophy through SUZ12 (Suppressor of Zeste 12 Protein Homolog)-mediated downregulation of MEF2A (Myocyte Enhancer Factor 2A). Circ Heart Fail. 2020;13(1):e006525.","journal-title":"Circ Heart Fail"},{"key":"1209_CR23","doi-asserted-by":"crossref","unstructured":"Li JH, Liu S, Zhou H, Qu LH, Yang JH. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucl Acids Res. 2014;42(Database issue):D92\u20137.","DOI":"10.1093\/nar\/gkt1248"},{"key":"1209_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.yjmcc.2017.06.015","volume":"109","author":"D Siede","year":"2017","unstructured":"Siede D, Rapti K, Gorska AA, Katus HA, Altm\u00fcller J, Boeckel JN, et al. Identification of circular RNAs with host gene-independent expression in human model systems for cardiac differentiation and disease. J Mol Cell Cardiol. 2017;109:48\u201356.","journal-title":"J Mol Cell Cardiol"},{"issue":"20","key":"1209_CR25","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1093\/eurheartj\/ehy085","volume":"39","author":"L Wang","year":"2018","unstructured":"Wang L, Zhang YL, Lin QY, Liu Y, Guan XM, Ma XL, et al. CXCL1-CXCR2 axis mediates angiotensin II-induced cardiac hypertrophy and remodelling through regulation of monocyte infiltration. Eur Heart J. 2018;39(20):1818\u201331.","journal-title":"Eur Heart J"},{"key":"1209_CR26","doi-asserted-by":"crossref","unstructured":"Shen L, Gan M, Tan Z, Jiang D, Jiang Y, Li M, et al. A novel class of tRNA-derived small non-coding RNAs respond to myocardial hypertrophy and contribute to intergenerational inheritance. Biomolecules. 2018;8(3).","DOI":"10.3390\/biom8030054"},{"issue":"11","key":"1209_CR27","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","volume":"20","author":"LS Kristensen","year":"2019","unstructured":"Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(11):675\u201391.","journal-title":"Nat Rev Genet"},{"issue":"33","key":"1209_CR28","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1093\/eurheartj\/ehv713","volume":"37","author":"K Wang","year":"2016","unstructured":"Wang K, Long B, Liu F, Wang JX, Liu CY, Zhao B, et al. A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223. Eur Heart J. 2016;37(33):2602\u201311.","journal-title":"Eur Heart J"},{"key":"1209_CR29","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ijcard.2019.04.006","volume":"292","author":"H Ni","year":"2019","unstructured":"Ni H, Li W, Zhuge Y, Xu S, Wang Y, Chen Y, et al. Inhibition of circHIPK3 prevents angiotensin II-induced cardiac fibrosis by sponging miR-29b-3p. Int J Cardiol. 2019;292:188\u201396.","journal-title":"Int J Cardiol"},{"key":"1209_CR30","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.ejphar.2017.11.031","volume":"818","author":"Y Li","year":"2018","unstructured":"Li Y, Wang J, Sun L, Zhu S. LncRNA myocardial infarction-associated transcript (MIAT) contributed to cardiac hypertrophy by regulating TLR4 via miR-93. Eur J Pharmacol. 2018;818:508\u201317.","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"1209_CR31","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.1093\/nar\/gkz141","volume":"47","author":"P Kong","year":"2019","unstructured":"Kong P, Yu Y, Wang L, Dou YQ, Zhang XH, Cui Y, et al. circ-Sirt1 controls NF-\u03baB activation via sequence-specific interaction and enhancement of SIRT1 expression by binding to miR-132\/212 in vascular smooth muscle cells. Nucleic Acids Res. 2019;47(7):3580\u201393.","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"1209_CR32","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/s41419-019-2127-7","volume":"10","author":"J Zhou","year":"2019","unstructured":"Zhou J, Zhang S, Chen Z, He Z, Xu Y, Li Z. CircRNA-ENO1 promoted glycolysis and tumor progression in lung adenocarcinoma through upregulating its host gene ENO1. Cell Death Dis. 2019;10(12):885.","journal-title":"Cell Death Dis"},{"key":"1209_CR33","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2015.11.015","volume":"244","author":"DM Rocha","year":"2016","unstructured":"Rocha DM, Caldas AP, Oliveira LL, Bressan J, Hermsdorff HH. Saturated fatty acids trigger TLR4-mediated inflammatory response. Atherosclerosis. 2016;244:211\u20135.","journal-title":"Atherosclerosis"},{"issue":"4","key":"1209_CR34","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1016\/j.bbrc.2018.06.169","volume":"503","author":"C Li","year":"2018","unstructured":"Li C, Zhou G, Feng J, Zhang J, Hou L, Cheng Z. Upregulation of lncRNA VDR\/CASC15 induced by facilitates cardiac hypertrophy through modulating miR-432-5p\/TLR4 axis. Biochem Biophys Res Commun. 2018;503(4):2407\u201314.","journal-title":"Biochem Biophys Res Commun"},{"issue":"17","key":"1209_CR35","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1002\/1873-3468.13161","volume":"592","author":"WS Albihlal","year":"2018","unstructured":"Albihlal WS, Gerber AP. Unconventional RNA-binding proteins: an uncharted zone in RNA biology. FEBS Lett. 2018;592(17):2917\u201331.","journal-title":"FEBS Lett"},{"key":"1209_CR36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.carpath.2019.04.005","volume":"42","author":"X Luo","year":"2019","unstructured":"Luo X, He S, Hu Y, Liu J, Chen X. Sp1-induced LncRNA CTBP1-AS2 is a novel regulator in cardiomyocyte hypertrophy by interacting with FUS to stabilize TLR4. Cardiovasc Pathol. 2019;42:21\u20139.","journal-title":"Cardiovasc Pathol"},{"issue":"11","key":"1209_CR37","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1002\/1873-3468.12646","volume":"591","author":"H Ederle","year":"2017","unstructured":"Ederle H, Dormann D. TDP-43 and FUS en route from the nucleus to the cytoplasm. FEBS Lett. 2017;591(11):1489\u2013507.","journal-title":"FEBS Lett"},{"issue":"4","key":"1209_CR38","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1159\/000490866","volume":"47","author":"Q Su","year":"2018","unstructured":"Su Q, Li L, Sun Y, Yang H, Ye Z, Zhao J. Effects of the TLR4\/Myd88\/NF-\u03baB signaling pathway on NLRP3 inflammasome in coronary microembolization-induced myocardial injury. Cell Physiol Biochem. 2018;47(4):1497\u2013508.","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"1209_CR39","doi-asserted-by":"publisher","first-page":"e0193003","DOI":"10.1371\/journal.pone.0193003","volume":"13","author":"J Cosin-Roger","year":"2018","unstructured":"Cosin-Roger J, Spalinger MR, Ruiz PA, Stanzel C, Terhalle A, Wolfram L, et al. Gp96 deficiency affects TLR4 functionality and impairs ERK and p38 phosphorylation. PloS one. 2018;13(2):e0193003.","journal-title":"PloS one."}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-022-01209-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-022-01209-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-022-01209-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T12:19:15Z","timestamp":1665404355000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10840-022-01209-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,12]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1209"],"URL":"https:\/\/doi.org\/10.1007\/s10840-022-01209-w","relation":{},"ISSN":["1383-875X","1572-8595"],"issn-type":[{"value":"1383-875X","type":"print"},{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,12]]},"assertion":[{"value":"16 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}